Fate Therapeutics Inc

Fate Therapeutics Inc

FATE

Market Cap$119.22M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Fate Therapeutics IncFate Therapeutics Inc-0.7--61%-0.3
$3.00

Target Price by Analysts

163.2% upsideFate Therapeutics Target Price DetailsTarget Price
$8.54

Current Fair Value

649.2% upside

Undervalued by 649.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$119.22 Million
Enterprise Value$162.03 Million
Dividend Yield$0 (0%)
Earnings per Share$-1.64
Beta2.23
Outstanding Shares118,375,540

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-0.7
PEG3.24
Price to Sales-
Price to Book Ratio0.57
Enterprise Value to Revenue12.15
Enterprise Value to EBIT-0.87
Enterprise Value to Net Income-1
Total Debt to Enterprise0.54
Debt to Equity0.3

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Fate Therapeutics Inc

CEO: William Rastetter